Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats

References

• Shin SM, Shim WJ, Park SM. Early changes of left ventricular function in young adults with never-treated hypertension and no left ventricular hypertrophy: relationships to ambulatory blood pressure monitoring. Clin Exp Hypertens 2014;30:1–7
   Google Scholar
• Hall JE. The kidney, hypertension, and obesity. Hypertension 2003;41:625–33
   PubMed Web of Science ®Google Scholar
• Whelton PK, Klag MJ. Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence. Hypertension 1989;13:I19–27
   PubMedGoogle Scholar
• Carlsson AC, Ruge T, Sundström J, et al. Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Hypertension 2013;62:1146–51
   PubMed Web of Science ®Google Scholar
• Santos PC, Krieger JE, Pereira AC. Renin-angiotensin system, hypertension, and chronic kidney disease: pharmacogenetic implications. J Pharmacol Sci 2012;120:77–88
   PubMed Web of Science ®Google Scholar
• Kita T, Yokota N, Ichiki Y, et al. Three-year safety and effectiveness of fixed-dose losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension under clinical setting (PALM-1 Extension Study). Clin Exp Hypertens 2012;34:498–503
   PubMed Web of Science ®Google Scholar
• Trott DW, Harrison DG. The immune system in hypertension. Adv Physiol Educ 2014;38:20–4
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. Immune mechanisms in hypertension and vascular injury. Clin Sci (Lond) 2014;126:267–74
   PubMed Web of Science ®Google Scholar
• Miguel-Carrasco JL, Zambrano S, Blanca AJ, et al. Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB. J Inflamm (Lond) 2010;7:21. doi:10.1186/1476-9255-7-21
   PubMed Web of Science ®Google Scholar
• Lukic L, Lalic NM, Rajkovic N, et al. Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention. Int J Environ Res Public Health 2014;11:3586–98
   PubMed Web of Science ®Google Scholar
• Kang YS. Obesity associated hypertension: new Insights into mechanism. Electrolyte Blood Press 2013;11:46–52
   PubMedGoogle Scholar
• Harrison DG, Marvar PJ, Titze JM. Vascular inflammatory cells in hypertension. Front Physiol 2012;3:128. doi:10.3389/fphys.2012.00128
   PubMed Web of Science ®Google Scholar
• Trott DW, Harrison DG. The immune system in hypertension. Adv Physiol Educ 2014;38:20–4
   PubMed Web of Science ®Google Scholar
• Chen C, Yu Z, Li Y, et al. Effects of berberine in the gastrointestinal tract – a review of actions and therapeutic implications. Am J Chin Med 2014;42:1053–70
   PubMed Web of Science ®Google Scholar
• Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008;57:712–17
   PubMed Web of Science ®Google Scholar
• Meng S, Wang LS, Huang ZQ, et al. Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention. Clin Exp Pharmacol Physiol 2012;39:406–11
   PubMed Web of Science ®Google Scholar
• Li Z, Geng YN, Jiang JD, Kong WJ. Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement Alternat Med 2014;2014:289264
   PubMed Web of Science ®Google Scholar
• Li MH, Zhang YJ, Yu YH, et al. Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy. Eur J Pharmacol 2014;728:67–76
   PubMed Web of Science ®Google Scholar
• Kang DG1, Sohn EJ, Kwon EK, et al. Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vascul Pharmacol 2002;39:281–6
   PubMed Web of Science ®Google Scholar
• Pérez-Rubio KG, González-Ortiz M, Martínez-Abundis E, et al. Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord 2013;11:366–9
   PubMed Web of Science ®Google Scholar
• Xie HH, Shen FM, Miao CY, Su DF. Blood pressure, baroreflex sensitivity, and end organ damage in hybrid offspring of spontaneously hypertensive rats and Sprague-Dawley rats. Acta Pharmacol Sin 2005;26:1049–56
   PubMed Web of Science ®Google Scholar
• Regner KR, Harmon AC, Williams JM, et al. Increased susceptibility to kidney injury by transfer of genomic segment from SHR onto Dahl S genetic background. Physiol Genomics 2012;44:629–37
   PubMed Web of Science ®Google Scholar
• Mihailovic-Stanojevic N1, Jovovic D, Miloradovic Z, et al. Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan. Nephrol Dial Transplant 2009;24:1142–50
   PubMed Web of Science ®Google Scholar
• Wu D, Wen W, Qi CL, et al. Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin. Phytomedicine 2012;19:712–18
   PubMed Web of Science ®Google Scholar
• Zhang Q1, Davis KJ, Hoffmann D, et al. Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats. Biomark Med 2014;8:85–94
   PubMed Web of Science ®Google Scholar
• Li HB, Cai Y, Qi CL, Lv JH. Effects and mechanism of berberine on the hypertensive renal injury rats induced by enriched high fat-salt-fructose diet. Zhong Yao Cai 2011;34:412–15
   PubMedGoogle Scholar
• Nguyen H, Chiasson VL, Chatterjee P, et al. Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res 2013;97:696–704
   PubMed Web of Science ®Google Scholar
• Krebs CF, Lange S, Niemann G, et al. Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate + angiotensin ii-induced hypertension. Hypertension 2014;63:565–71
   PubMed Web of Science ®Google Scholar